These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6221991)

  • 1. Lethal GVHD across minor histocompatibility barriers: nature of the effector cells and role of the H-2 complex.
    Korngold R; Sprent J
    Immunol Rev; 1983; 71():5-29. PubMed ID: 6221991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Features of T cells causing H-2-restricted lethal graft-vs.-host disease across minor histocompatibility barriers.
    Korngold R; Sprent J
    J Exp Med; 1982 Mar; 155(3):872-83. PubMed ID: 6977610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L3T4-positive T cells participate in the induction of graft-vs-host disease in response to minor histocompatibility antigens.
    Hamilton BL
    J Immunol; 1987 Oct; 139(8):2511-5. PubMed ID: 3498761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of T cell subsets in lethal graft-versus-host disease (GVHD) directed to class I versus class II H-2 differences. I. L3T4+ cells can either augment or retard GVHD elicited by Lyt-2+ cells in class I different hosts.
    Sprent J; Schaefer M; Gao EK; Korngold R
    J Exp Med; 1988 Feb; 167(2):556-69. PubMed ID: 2964497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative selection of T cells causing lethal graft-versus-host disease across minor histocompatibility barriers. Role of the H-2 complex.
    Korngold R; Sprent J
    J Exp Med; 1980 May; 151(5):1114-24. PubMed ID: 6966318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lethal graft-vs-host disease across major histocompatibility barriers: requirement for leucyl-leucine methyl ester sensitive cytotoxic T cells.
    Thiele DL; Charley MR; Calomeni JA; Lipsky PE
    J Immunol; 1987 Jan; 138(1):51-7. PubMed ID: 2946780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow.
    Korngold R; Sprent J
    J Exp Med; 1978 Dec; 148(6):1687-98. PubMed ID: 363972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of immunologic tolerance to host minor histocompatibility antigens following allogeneic bone marrow transplantation in mice.
    Perreault C; Allard A; Brochu S; Poupart C; Fontaine P; Bélanger R; Gyger M
    Bone Marrow Transplant; 1990 Aug; 6(2):127-35. PubMed ID: 2145050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosuppressor and allohelper T cells in acute and chronic graft-vs.-host disease. II. F1 recipients carrying mutations at H-2K and/or I-A.
    Rolink AG; Pals ST; Gleichmann E
    J Exp Med; 1983 Feb; 157(2):755-71. PubMed ID: 6218218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface markers of T cells causing lethal graft-vs-host disease to class I vs class II H-2 differences.
    Korngold R; Sprent J
    J Immunol; 1985 Nov; 135(5):3004-10. PubMed ID: 3876371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of T cell subsets in lethal graft-versus-host disease (GVHD) directed to class I versus class II H-2 differences. II. Protective effects of L3T4+ cells in anti-class II GVHD.
    Sprent J; Schaefer M; Korngold R
    J Immunol; 1990 Apr; 144(8):2946-54. PubMed ID: 1969878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell subsets involved in lethal graft-versus-host disease directed to immunodominant minor histocompatibility antigens.
    Berger M; Wettstein PJ; Korngold R
    Transplantation; 1994 Apr; 57(7):1095-102. PubMed ID: 7909395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor T cells lacking Fas ligand and perforin retain the capacity to induce severe GvHD in minor histocompatibility antigen mismatched bone-marrow transplantation recipients.
    Marks L; Altman NH; Podack ER; Levy RB
    Transplantation; 2004 Mar; 77(6):804-12. PubMed ID: 15077018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biology of graft-vs.-host disease.
    Korngold R
    Am J Pediatr Hematol Oncol; 1993 Feb; 15(1):18-27. PubMed ID: 8447559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variable capacity of L3T4+ T cells to cause lethal graft-versus-host disease across minor histocompatibility barriers in mice.
    Korngold R; Sprent J
    J Exp Med; 1987 Jun; 165(6):1552-64. PubMed ID: 3108446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of lethal graft-versus-host disease following allogeneic bone marrow transplantation in mice by short course administration of LF 08-0299.
    Annat J; Churaqui E; Dutartre P; Bruley-Rosset M
    Transplantation; 1996 Sep; 62(6):721-9. PubMed ID: 8824467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of delayed type hypersensitivity to host histocompatibility antigens during graft-versus-host reactions.
    Benner R; Wolters EA; Bril H; Molendijk A; van Oudenaren A
    Immunol Rev; 1985 Dec; 88():25-57. PubMed ID: 2935486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of correlation between cytolytic T lymphocytes and lethal murine graft-versus-host disease in response to minor histocompatibility antigens.
    Hamilton BL
    Transplantation; 1984 Oct; 38(4):357-60. PubMed ID: 6388062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-recipient cytotoxic T lymphocyte precursors are present in the spleens of mice with acute graft versus host disease due to minor histocompatibility antigens.
    Hamilton BL; Bevan MJ; Parkman R
    J Immunol; 1981 Feb; 126(2):621-5. PubMed ID: 6450246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute and chronic graft-versus-host disease induced by minor histocompatibility antigens in mice.
    Hamilton BL; Parkman R
    Transplantation; 1983 Aug; 36(2):150-5. PubMed ID: 6349039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.